Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.658
-0.022 (-0.81%)
Jan 23, 2026, 4:00 PM EST - Market closed
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $9.71 million as of January 23, 2026. Its market cap has decreased by -57.74% in one year.
Market Cap
9.71M
Enterprise Value
4.99M
1-Year Change
-57.74%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $9.71M, a decrease of -94.15%. That is a compound annual growth rate of -23.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 9.79M | 20.18% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 10.59M |
| BioRestorative Therapies | 10.39M |
| Aptevo Therapeutics | 9.27M |
| Ernexa Therapeutics | 9.26M |
| MetaVia | 9.24M |
| Alzamend Neuro | 9.24M |
| BioVie | 9.04M |
| Abpro Holdings | 8.88M |